Enterococcus faecalis-Induced Macrophage Necroptosis Promotes Refractory Apical Periodontitis

Xingzhu Dai1, Rongyang Ma1, Weiyi Jiang1

  • 1Department of Stomatology, Nanfang Hospital, Southern Medical Universitygrid.284723.8, Guangzhou, China.

Microbiology Spectrum
|June 16, 2022
PubMed

Insights

Refractory periapical periodontitis involves necroptosis, a cell death pathway. Targeting receptor-interacting protein kinase 3 (RIPK3) and mixed lineage kinase domain-like protein (MLKL) may offer new treatments for this challenging oral infection.

Area of Science:

  • Immunology
  • Cell Biology
  • Oral Pathology

Background:

  • Refractory periapical periodontitis (RAP) persists despite treatment, often linked to Enterococcus faecalis.
  • Necroptosis, a pro-inflammatory cell death, is implicated in various diseases, but its role in RAP is unknown.

Purpose of the Study:

  • To investigate the activation of the RIPK3/MLKL necroptosis pathway in human RAP lesions.
  • To determine the role of necroptosis in E. faecalis-induced RAP pathogenesis in vivo and in vitro.

Main Methods:

  • Analysis of RIPK3 and MLKL phosphorylation in patient periapical lesions.
  • Utilizing RIPK3-deficient mice and in vitro macrophage models infected with E. faecalis.
  • Employing specific inhibitors for RIPK3 and MLKL.

Main Results:

  • Elevated RIPK3 and MLKL phosphorylation in human RAP lesions.
  • Necroptosis was induced in an E. faecalis mouse model, with RIPK3 deficiency alleviating inflammation and bone loss.
  • E. faecalis infection triggered necroptosis in macrophages via the RIPK3/MLKL pathway, inhibited by specific blockers.

Conclusions:

  • RIPK3/MLKL-mediated macrophage necroptosis is a key factor in refractory periapical periodontitis development.
  • Targeting necroptosis pathways presents a promising therapeutic strategy for RAP and other E. faecalis-related infections.